Clinical Trial Update: ESGVS: Sclerotherapy With Lauromacrogol [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sclerotherapy with lauromacrogol for chronic venous insufficiency involving the saphenous vein has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency

Drugs mentioned

• Lauromacrogol (lauromacrogol)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Venous Insufficiency, Saphenous Vein | Phase 3 | Status: COMPLETED